Goldman Sachs
SLGCW

Goldman Sachs’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Goldman Sachs’s Portfolio SLGCW Stock Details SLGCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,299
Closed -$48K – 7014
2021
Q4 		$48K Sell
14,299
-3,065
-18% -$11.7K ﹤0.01% 6276
2021
Q3 		$60K Buy
+17,364
New +$53.5K ﹤0.01% 6010

Other funds holding SLGCW

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs's SLGCW Position: Q1 2022 in Review

Goldman Sachs sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2022, closing a stake of 14,299 shares — an estimated $48K sold.

Goldman Sachs first reported a position in SLGCW in Q3 2021 and held it in 2 quarters. The position peaked at $60K in Q3 2021. 28 funds tracked by Wall St. Rank hold SLGCW as of Q1 2022.

  • Goldman Sachs reported no remaining SomaLogic, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 14,299 SomaLogic, Inc. Warrant shares in Q1 2022, an estimated $48K.
  • Goldman Sachs first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 2 quarters.
  • Goldman Sachs's SomaLogic, Inc. Warrant position peaked at $60K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.